Webinar: Regulatory Challenges and Opportunities for PT11 and PT12 Biocidal Products
Friday, June 19, at 11:00 -12:15 am (CET)
Many active substances used in PT11 and PT12 are currently still part of the EU Review Programme and the end of their evaluation is approaching.
⚠️Active substance approvals can be expected relatively soon; prepare for product authorisation to keep your products on the market.
In this webinar, regulators, efficacy testing experts and regulatory consultants share practical insights on their experience and how to prepare.
Speakers:
CTGB (NL Competent Authority)
Eurofins (Testing laboratory)
Elements Advisory (Risk Assessment – ERA & HH RA)
Content:
Key differences between PT11 and PT12 use patterns
How to approach risk assessment (HH & ERA)
Efficacy testing strategies and expectations
Impact of the Review Programme on your timelines
Common pitfalls in PT11/PT12-related BPR dossiers
👉 Register now to learn how to succesfully prepare your PT11/12 BPR dossier
Please express your interest using the form below. Please note that this is not a binding step.